Why did the units spike 7.12% in a single day?
On July 28, 2026, HOFC11 — a Brazilian Real Estate Investment Trust (FII) focused on office properties in São Paulo, managed by Hedge Investments — disclosed a binding proposal of R$86.42 million to sell the Morumbi Tower (Av. Morumbi, 8,234, São Paulo). The transaction is structured as an acquisition of HOFC Empreendimentos' shares — the SPE (special-purpose vehicle created solely to hold this one building's bare ownership) — rather than a direct property transfer. Payment would be made in full upon closing, with the caveat that part may be settled in highly liquid REIT units. The market's read the next day was straightforward: the fund is about to convert its most valuable remaining asset into cash, and unitholders could finally see a return of capital. Hence the 7.12% surge.
The investment logic is arithmetic. HOFC11 trades at R$34.30 against a NAV of R$57.03 per unit (P/NAV of 0.60, meaning a 40% discount to book value). If the Morumbi sale crystallizes value and the fund proceeds to an orderly liquidation — which in practice means selling all remaining assets, paying off all debts, and distributing leftover cash pro-rata to unitholders — those who entered at R$34.30 would pocket the gap up to NAV. The thesis is mathematically defensible. The catch is that between today's proposal and actual distributions sit a mandatory toll (the mortgage-backed CRI debt) and a queue of conditionalities. That's what this piece unpacks.
The mandatory toll: CRI Série 288
The Morumbi Tower is the collateral for CRI Série 288 — a R$52.46M debt (24.17% of NAV), accruing at IPCA (Brazil's consumer inflation index) plus 7.70% per year until 2032. A CRI (Certificado de Recebíveis Imobiliários) is, in plain terms, a real-estate-backed loan where the property itself serves as collateral (fiduciary alienation — an arrangement similar to a mortgage lien). As long as this debt stands, the tower is legally encumbered by the creditor. This is why the proposal includes a suspensive condition: it is only effective if the holders of CRI Série 288 consent to the transaction. Without their approval, there is no sale — and without retiring the debt, the sale proceeds cannot flow through to distributions. Bottom line: a substantial portion of the R$86.42M has a prior claim before any cent reaches a unitholder.
The math that matters: net proceeds per unit
HOFC11 has approximately 3,779,000 units outstanding. Starting from the gross offer and tracing the payments in the order they must occur:
In other words: of the R$22.87 per unit that the headline implies, the Morumbi sale alone delivers somewhere between R$7.70 and R$8.19 to the unitholder — nearly two-thirds evaporates into the CRI and transaction costs. The fund will also bear the ITBI (a Brazilian property-transfer tax similar to stamp duty) and an air-conditioning retrofit, both cited in news sources as seller obligations. Morumbi alone, then, does not justify a unit price of R$34.30. What matters is everything still in the portfolio beyond Morumbi.
What else is left in the portfolio
HOFC11 has been in controlled liquidation for months — selling assets one by one. Three remaining pieces make up the portfolio's residual value:
| Asset | Status | Potential value | Uncertainty level |
|---|---|---|---|
| Morumbi Tower Av. Morumbi, 8,234, São Paulo · 88% occupied |
Binding proposal of R$86.42M (Jul 28, 2026) | ≈ R$7.70–8.19/unit net (after CRI and costs) | Conditional on CRI 288 holders' approval |
| Birmann 20 26% occupancy rate |
Non-binding MOU signed Apr 16, 2026 (~R$72M), in 8-month due diligence | ≈ R$19/unit gross if completed | High — buyer may walk or negotiate further discount |
| Citadel I FII 576,800 units · ~27% of portfolio |
Received as payment for the sale of Ed. Saliba | Depends on leasing pace post-renovation (Jul 2026) | Medium — 66% vacant in May 2026; leasing in progress |
Adding all three legs (net Morumbi + gross Birmann + Citadel), the total recoverable value per unit can, in a favorable scenario, exceed R$34.30 and approach the NAV of R$57.03 — and that is exactly what the market priced in with the 7.12% jump. The arithmetic works. But it requires all three events to materialize, each carrying its own conditional.
The "ifs" that could derail the thesis
Before treating the rally as a layup, here are the moving parts that need to go right — and what can go wrong:
Four conditions standing between the proposal and cash in hand
1. CRI holders must approve. The Série 288 creditors hold the Morumbi as collateral and have effective veto power through the suspensive condition. Without their sign-off, the proposal simply doesn't convert into a transaction.
2. Birmann 20 may not close. The MOU is non-binding and subject to an 8-month due diligence period. The buyer may withdraw or push for a deeper discount — the building is just 26% leased, which already drove the agreed price well below appraised value.
3. Citadel I depends on leasing. The 576,800 units received for Ed. Saliba are worth only as much as the building fills up. In May 2026 it was 66% vacant, with leasing expected to ramp after the July 2026 renovation completion.
4. Partial payment in REIT units carries liquidity risk. If part of the R$86.42M comes as units of another FII, HOFC11 is exchanging real estate for a tradeable asset whose monetization speed depends on daily trading volume — it may take time to convert into actual cash.
None of these invalidates the overall thesis. But each one adds time and introduces a discount. The backdrop is also worth noting: the fund has paid no distributions for 23 months (since July 2024), and closed April 2026 with just R$596k in cash — a 46% drop in a single month. That cash squeeze, already flagged in our May 2026 analysis on the fund's liquidity crunch, is precisely what makes selling Morumbi not just opportune but operationally necessary to keep the fund solvent through the end of its liquidation.
How fund liquidation works — step by step
If the sale closes and the CRI holders give consent, the fund plans to call an extraordinary general meeting (AGE — Assembleia Geral Extraordinária) to vote on winding up the fund. Liquidation, in practice, means:
- Selling all remaining assets (Birmann 20, Citadel I units, and anything else) and converting them entirely into cash.
- Paying off all liabilities — chiefly the CRI Série 288, whose collateral is the very property being sold.
- Covering all operating expenses until the fund is formally wound down (management fee, audit, legal, transfer taxes, renovation costs).
- Returning the remaining cash to unitholders in proportion to their holdings and formally closing the fund.
The point retail investors tend to underestimate is the timeline. Between the AGE, completing pending sales, leasing the Citadel, and standard deal-closing formalities, the interval until the last payment arrives could stretch from one to three years. During that window, unitholders remain without distributions and exposed to every "if" going sideways.
Verdict
Analysis: the rally is defensible — but it's not a free lunch
The 7.12% appreciation is understandable and mathematically sustainable — provided the three events (Morumbi sale with CRI approval, Birmann 20 closing, and Citadel I monetization) all materialize. In that scenario, total recoverable value per unit should exceed R$34.30 and approach the NAV of R$57.03. But the timeline to actual distributions is uncertain (one to three years) and loaded with conditionalities.
For existing HOFC11 holders: this news has injected price and liquidity into an asset that went nearly two years without distributions and with razor-thin cash. This may be the right window to consider an exit or position reduction — locking in some gain now rather than waiting out a full liquidation with all its contingencies.
For new buyers: at R$34.30, with a P/NAV of 0.60 and NAV of R$57.03, the discount is already pricing in the risk. This isn't a screaming bargain — it's the correct valuation of a fund in orderly liquidation with real conditionalities. Anyone entering should understand they're making an event-driven bet, not buying income. Our rating remains SELL · 2.9/10 for income-oriented investors, with the acknowledgment that the Morumbi transaction is a concrete, material step forward in the liquidation process.
For the full picture — portfolio breakdown, debt structure, sales history, and updated rating — see the complete HOFC11 analysis.
